Cargando…
An Omics View of Emery–Dreifuss Muscular Dystrophy
Recent progress in Omics technologies has started to empower personalized healthcare development at a thorough biomolecular level. Omics have subsidized medical breakthroughs that have started to enter clinical proceedings. The use of this scientific know-how has surfaced as a way to provide a more...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7354601/ https://www.ncbi.nlm.nih.gov/pubmed/32549253 http://dx.doi.org/10.3390/jpm10020050 |
_version_ | 1783558122774724608 |
---|---|
author | Vignier, Nicolas Muchir, Antoine |
author_facet | Vignier, Nicolas Muchir, Antoine |
author_sort | Vignier, Nicolas |
collection | PubMed |
description | Recent progress in Omics technologies has started to empower personalized healthcare development at a thorough biomolecular level. Omics have subsidized medical breakthroughs that have started to enter clinical proceedings. The use of this scientific know-how has surfaced as a way to provide a more far-reaching view of the biological mechanisms behind diseases. This review will focus on the discoveries made using Omics and the utility of these approaches for Emery–Dreifuss muscular dystrophy. |
format | Online Article Text |
id | pubmed-7354601 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-73546012020-07-23 An Omics View of Emery–Dreifuss Muscular Dystrophy Vignier, Nicolas Muchir, Antoine J Pers Med Review Recent progress in Omics technologies has started to empower personalized healthcare development at a thorough biomolecular level. Omics have subsidized medical breakthroughs that have started to enter clinical proceedings. The use of this scientific know-how has surfaced as a way to provide a more far-reaching view of the biological mechanisms behind diseases. This review will focus on the discoveries made using Omics and the utility of these approaches for Emery–Dreifuss muscular dystrophy. MDPI 2020-06-15 /pmc/articles/PMC7354601/ /pubmed/32549253 http://dx.doi.org/10.3390/jpm10020050 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Vignier, Nicolas Muchir, Antoine An Omics View of Emery–Dreifuss Muscular Dystrophy |
title | An Omics View of Emery–Dreifuss Muscular Dystrophy |
title_full | An Omics View of Emery–Dreifuss Muscular Dystrophy |
title_fullStr | An Omics View of Emery–Dreifuss Muscular Dystrophy |
title_full_unstemmed | An Omics View of Emery–Dreifuss Muscular Dystrophy |
title_short | An Omics View of Emery–Dreifuss Muscular Dystrophy |
title_sort | omics view of emery–dreifuss muscular dystrophy |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7354601/ https://www.ncbi.nlm.nih.gov/pubmed/32549253 http://dx.doi.org/10.3390/jpm10020050 |
work_keys_str_mv | AT vigniernicolas anomicsviewofemerydreifussmusculardystrophy AT muchirantoine anomicsviewofemerydreifussmusculardystrophy AT vigniernicolas omicsviewofemerydreifussmusculardystrophy AT muchirantoine omicsviewofemerydreifussmusculardystrophy |